Yamaguchi S, Narukawa M. Combinations of drug candidate properties affecting development success and discontinuation for five diseases: Lymphoma, non-small cell lung cancer, arthritis, depression, and Alzheimer's disease. J Clin Pharmacol 2022 Apr 14. doi: 10.1002/jcph.2063.
PMID: 35420708